Celularity Announces Phase 1 Data Showing That MLASC Therapy in Patients With Crohn's Disease May Be a Therapeutic Option to Manage Inflammatory Bowel Diseases and Prevent Fistula Formation

Early-stage data presented at the 26th Annual Meeting of the American Society for Gene and Cell Therapy demonstrate that therapy with placental-derived mesenchymal-like adherent stem cells results in... | June 11, 2023

Related Keywords

United States ,American ,Los Angeles ,Robertj Hariri ,American Society Of Gene Cell Therapy ,Celularity Inc ,Globenewswire Inc ,American Society For Gene ,Securities Exchange ,Exchange Commission ,Nasdaq ,Annual Meeting ,Cell Therapy ,Derived Mesenchymal ,Like Adherent Stromal Cell ,Therapy Results ,Protein Signatures Associated ,Fistula Formation ,Poster Session ,Private Securities Litigation Reform Act ,Securities Act ,Securities Exchange Act ,Chief Communications ,